Study Challenges How Cancer Drugs Called HDAC Inhibitors Actually Work
Cancer
Summary
Researchers at Baylor College of Medicine are challenging decades of scientific understanding about how histone deacetylase (HDAC) inhibitors treat cancer. These drugs have long been believed to work by blocking HDAC enzymes that alter gene expression and drive cancer development. This new research proposes reconsidering the fundamental mechanisms of how these medications function at the molecular level. Understanding the true mechanism of action could lead to improved cancer treatments and more effective therapeutic strategies for patients.
